Skates SJ - Search Results

1

Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Kalsi J, Gentry-Maharaj A, Ryan A, Singh N, Burnell M, Massingham S, Apostolidou S, Sharma A, Williamson K, Seif M, Mould T, Woolas R, Dobbs S, Leeson S, Fallowfield L, Skates SJ, Parmar M, Campbell S, Jacobs I, McGuire A, Menon U. Kalsi J, et al. Among authors: skates sj. Cancers (Basel). 2021 Feb 18;13(4):858. doi: 10.3390/cancers13040858. Cancers (Basel). 2021. PMID: 33670571 Free PMC article.

2

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH. Jacobs IJ, et al. BMJ. 1996 Nov 30;313(7069):1355-8. doi: 10.1136/bmj.313.7069.1355. BMJ. 1996. PMID: 8956699 Free PMC article. Clinical Trial.

3

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Jacobs IJ, et al. Among authors: skates sj. Lancet. 1999 Apr 10;353(9160):1207-10. doi: 10.1016/S0140-6736(98)10261-1. Lancet. 1999. PMID: 10217079 Clinical Trial.

4

Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.

Jeyarajah AR, Ind TE, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Cancer. 1999 May 1;85(9):2068-72. doi: 10.1002/(sici)1097-0142(19990501)85:9<2068::aid-cncr25>3.0.co;2-8. Cancer. 1999. PMID: 10223249 Clinical Trial.

5

Increased mortality in postmenopausal women with serum CA125 elevation.

Jeyarajah AR, Ind TE, MacDonald N, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Gynecol Oncol. 1999 May;73(2):242-6. doi: 10.1006/gyno.1999.5350. Gynecol Oncol. 1999. PMID: 10329041 Clinical Trial.

6

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: skates sj. Br J Cancer. 1999 Jul;80(10):1644-7. doi: 10.1038/sj.bjc.6690575. Br J Cancer. 1999. PMID: 10408412 Free PMC article.

7

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: skates sj. BJOG. 2000 Feb;107(2):165-9. doi: 10.1111/j.1471-0528.2000.tb11685.x. BJOG. 2000. PMID: 10688498

8

Factors influencing serum CA125II levels in healthy postmenopausal women.

Pauler DK, Menon U, McIntosh M, Symecko HL, Skates SJ, Jacobs IJ. Pauler DK, et al. Among authors: skates sj. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):489-93. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352859

9

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ. Skates SJ, et al. J Clin Oncol. 2003 May 15;21(10 Suppl):206s-210s. doi: 10.1200/JCO.2003.02.955. J Clin Oncol. 2003. PMID: 12743136

10

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr. Skates SJ, et al. J Clin Oncol. 2004 Oct 15;22(20):4059-66. doi: 10.1200/JCO.2004.03.091. Epub 2004 Sep 20. J Clin Oncol. 2004. PMID: 15381683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page